Clinical Trial Update: Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse [Phase 4]

View source ↗

Summary

A Phase 4 pilot study of Vyvanse (lisdexamfetamine) in adolescents with ADHD at risk for substance abuse has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2011-11-29